29.00
-0.06 (-0.21%)
-0.06 (-0.21%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.18 | 0.62% | 29.06 | 27.50 | 29.25 | 28.68 | 28.88 | 00:00:07 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 26.56 | 32.00 | 5.44 | 17.0% | 1 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 9,220 | 950,076 | $ 28.36 | $ 26,943,753 | 2,691,114 | 9.82 - 39.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:57 | 25 | $ 29.00 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.68B | 126.50M | $ -123.58M | -1.59 | - | 105.72M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 30.80 | 33.99 | 27.09 | 29.79 | 1,871,654 | -1.74 | -5.65% |
| 1 Month | 35.78 | 39.10 | 18.70 | 28.27 | 2,468,879 | -6.72 | -18.78% |
| 3 Months | 27.89 | 39.10 | 18.70 | 28.48 | 1,956,886 | 1.17 | 4.2% |
| 6 Months | 19.43 | 39.10 | 17.78 | 26.45 | 1,542,438 | 9.63 | 49.56% |
| 1 Year | 9.96 | 39.10 | 9.82 | 22.40 | 1,611,663 | 19.10 | 191.77% |
| 3 Years | 7.50 | 39.10 | 4.45 | 16.80 | 1,117,774 | 21.56 | 287.47% |
| 5 Years | 13.06 | 39.10 | 4.24 | 15.24 | 815,866 | 16.00 | 122.51% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. It's lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. |
